Intramyocardial transfer of hepatocyte growth factor as an adjunct to CABG: phase I clinical study.

MLA

Kim, J. S., et al. “Intramyocardial Transfer of Hepatocyte Growth Factor as an Adjunct to CABG: Phase I Clinical Study.” Gene Therapy, vol. 20, no. 7, July 2013, pp. 717–22. EBSCOhost, https://doi.org/10.1038/gt.2012.87.

APA

Kim, J. S., Hwang, H. Y., Cho, K. R., Park, E.-A., Lee, W., Paeng, J. C., Lee, D. S., Kim, H.-K., Sohn, D.-W., & Kim, K.-B. (2013). Intramyocardial transfer of hepatocyte growth factor as an adjunct to CABG: phase I clinical study. Gene Therapy, 20(7), 717–722. https://doi.org/10.1038/gt.2012.87

Chicago

Kim, J S, H Y Hwang, K R Cho, E-A Park, W Lee, J C Paeng, D S Lee, H-K Kim, D-W Sohn, and K-B Kim. 2013. “Intramyocardial Transfer of Hepatocyte Growth Factor as an Adjunct to CABG: Phase I Clinical Study.” Gene Therapy 20 (7): 717–22. doi:10.1038/gt.2012.87.